Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Abeona Therapeutics (ABEO) Profit After Tax: 2011-2024

Historic Profit After Tax for Abeona Therapeutics (ABEO) over the last 13 years, with Dec 2024 value amounting to -$63.7 million.

  • Abeona Therapeutics' Profit After Tax rose 82.95% to -$5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $82.3 million, marking a year-over-year increase of 215.93%. This contributed to the annual value of -$63.7 million for FY2024, which is 17.62% down from last year.
  • Abeona Therapeutics' Profit After Tax amounted to -$63.7 million in FY2024, which was down 17.62% from -$54.2 million recorded in FY2023.
  • In the past 5 years, Abeona Therapeutics' Profit After Tax registered a high of -$39.7 million during FY2022, and its lowest value of -$84.9 million during FY2021.
  • In the last 3 years, Abeona Therapeutics' Profit After Tax had a median value of -$54.2 million in 2023 and averaged -$52.5 million.
  • Per our database at Business Quant, Abeona Therapeutics' Profit After Tax skyrocketed by 53.26% in 2022 and then plummeted by 36.51% in 2023.
  • Over the past 5 years, Abeona Therapeutics' Profit After Tax (Yearly) stood at -$84.2 million in 2020, then dropped by 0.83% to -$84.9 million in 2021, then soared by 53.26% to -$39.7 million in 2022, then crashed by 36.51% to -$54.2 million in 2023, then fell by 17.62% to -$63.7 million in 2024.